Evidence map›Paper›PMID 27020439›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2016

Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation.

Patrick Müller, Philipp Halbfass, Attila Szöllösi, Johannes-Wolfgang Dietrich, Franziska Fochler, Karin Nentwich, Markus Roos, Joachim Krug, Rainer Schmitt, Andreas Mügge and 1 more

Abstract readControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Meta-analysis of the safety and efficacy of using minimally interrupted novel oral anticoagulants in patients undergoing catheter ablation for atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2021
    Pooled it
  4. Review
  5. Review
  6. Review
  7. Atrial fibrillation ablation: is common practice far from guidelines' world? The Italian experience from a national survey.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2022
    Article
  8. Article
  9. Article
  10. Feasibility and safety of uninterrupted apixaban in patients undergoing radiofrequency ablation for atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Patrick MüllerHeart Center Bad Neustadt, Clinic for Interventional Electrophysiology, Bad Neustadt an der Saale, Bavaria, Germany. mueller.patr@googlemail.com.
Philipp HalbfassHeart Center Bad Neustadt, Clinic for Interventional Electrophysiology, Bad Neustadt an der Saale, Bavaria, Germany.
Attila SzöllösiHeart Center Bad Neustadt, Clinic for Interventional Electrophysiology, Bad Neustadt an der Saale, Bavaria, Germany.
Johannes-Wolfgang DietrichUniversity Hospital Bergmannsheil, Clinic for Cardiology and Angiology, Ruhr-University Bochum, Bochum, NRW, Germany.
Franziska FochlerHeart Center Bad Neustadt, Clinic for Interventional Electrophysiology, Bad Neustadt an der Saale, Bavaria, Germany.
Karin NentwichHeart Center Bad Neustadt, Clinic for Interventional Electrophysiology, Bad Neustadt an der Saale, Bavaria, Germany.
Markus RoosHeart Center Bad Neustadt, Clinic for Interventional Electrophysiology, Bad Neustadt an der Saale, Bavaria, Germany.
Joachim KrugHeart Center Bad Neustadt, Clinic for Interventional Electrophysiology, Bad Neustadt an der Saale, Bavaria, Germany.
Rainer SchmittHeart Center Bad Neustadt, Clinic for Radiology, Bad Neustadt an der Saale, Bavaria, Germany.
Andreas MüggeUniversity Hospital Bergmannsheil, Clinic for Cardiology and Angiology, Ruhr-University Bochum, Bochum, NRW, Germany.
Thomas DenekeHeart Center Bad Neustadt, Clinic for Interventional Electrophysiology, Bad Neustadt an der Saale, Bavaria, Germany.
Rhön-Klinikum · DEBG University Hospital Bergmannsheil Bochum · DERuhr University Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSilent cerebral events (SCEs) have been observed on diffusion-weighted cerebral magnetic resonance imaging (MRI) in a substantial number of asymptomatic patients after atrial fibrillation (AF) ablation procedures. The purpose of this study was to investigate if periprocedural oral anticoagulation (OAC) management affects the incidence of new-onset SCE after radiofrequency catheter ablation (RFCA) of AF. METHODS AND

resultsOne hundred ninety-two consecutive patients (64 ± 10.1 years, 38.5 % women) with symptomatic paroxysmal (n = 80, 41.7 %) or persistent AF undergoing RFCA of AF were prospectively enrolled. Periprocedural anticoagulation strategies were defined as uninterrupted use of novel oral anticoagulants (NOACs) (group I, n = 64), interrupted use of NOACs (group II, n = 42), continuation of vitamin K antagonist (VKA) with an international normalized ratio (INR) between 2.0 and 3.0 (group III, n = 43), and VKA discontinuation bridged with low molecular weight heparin (group IV, n = 43). Cerebral MRI was performed 1 to 2 days after RFCA for detection of new SCE. Overall, new SCEs were detected in 41 patients (21.4 %) after AF ablation. New SCEs were detected in 12.5 % in group I, 35.7 % in group II, 18.6 % in group III, and 23.3 % in group IV (p < 0.05). Multivariable logistic regression analysis revealed persistent AF and discontinuation of periprocedural OAC (group II and IV) to be independent predictors for the development of SCE. No relevant complications were identified.

conclusionsPeriprocedural continuation of NOAC as well as continuation of VKA seems to be safe and significantly reduce the occurrence of SCE after AF ablation.

Indexed as

AnticoagulantsAsymptomatic DiseasesAtrial FibrillationCatheter AblationCausalityComorbidityFemaleGermanyHumansIncidenceMaleMiddle AgedPostoperative ComplicationsPremedicationRisk FactorsStrokeAnticoagulantsAnticoagulation managementAtrial fibrillationCatheter ablationMagnetic resonance imagingSilent cerebral events

Identifiers

PMID27020439
OpenAlexW2323432212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.